Recalls & alerts

171 alerts recorded, refreshed every six hours. Filter by source or category.

• openFDA · August 19, 2026High risk

  Baxter Healthcare Corporation : Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only,…

  Baxter Healthcare Corporation is recalling Cefazolin in Dextrose Injection, USP, 2g/100mL single-dose infusion bags. The product contains particulate matter, which poses a risk of serious harm to patients receiving the intravenous infusion. Consumers should stop using the recalled product and contact their healthcare provider or pharmacy for further instructions.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102,…

  Apollo Care is recalling its Semaglutide 5mg (1mg/mL) and Glycine 25 mg (5mg/mL) sterile multi-dose vials for injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, posing a risk to patients. Consumers should stop using the recalled vials and contact their pharmacist or Apollo Care for return instructions.

  drugs
• openFDA · August 19, 2026Moderate risk

  Novartis Pharmaceuticals Corporation : Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis…

  Novartis is recalling Diovan (valsartan) 160 mg tablets, 90-count bottles, made by Patheon and distributed nationwide. The tablets fail dissolution specifications, so they may not dissolve properly and deliver the full dose, affecting patients who take this specific product. Consumers should check the lot number and return the recalled bottles to their pharmacy or contact Novartis for replacement.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO…

  Apollo Care is recalling Semaglutide 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vials for subcutaneous injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, posing a risk to patients nationwide. Consumers should stop using the recalled vials and contact their healthcare provider or pharmacy for guidance.

  drugs
• openFDA · August 19, 2026Moderate risk

  Shoolin Pharma Chem LLP : TADALAFIL USP, 0.500 KG, 0.500KG(500gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes,…

  Shoolin Pharma Chem LLP is recalling Tadalafil USP, a prescription compounding ingredient sold in 0.5 kg bags. The product may be ineffective or unsafe due to manufacturing deviations, affecting patients who receive compounded medications made with it. Consumers should stop using any medication compounded with this ingredient and contact their pharmacist for a replacement.

  drugs
• openFDA · August 19, 2026Moderate risk

  Shoolin Pharma Chem LLP : TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes,…

  Shoolin Pharma Chem LLP is recalling Tadalafil USP, a bulk drug ingredient sold in 100-gram bags for prescription compounding. The product was made without proper manufacturing controls, posing a quality and safety risk to patients receiving compounded medications made with it. Consumers should contact their pharmacist or healthcare provider to check if their medicine contains this recalled ingredient and follow their guidance.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.…

  Apollo Care is recalling Semaglutide 9mg (4.5 mg/mL) 2 mL sterile multi-dose vials for subcutaneous injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, which can harm patients who inject the drug. Consumers should stop using the recalled vials and contact Apollo Care or their pharmacy for return and replacement instructions.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste…

  Apollo Care is recalling semaglutide 10 mg (5 mg/mL) with glycine, 2 mL sterile multi-dose vials for injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, posing a risk to patients who inject the product. Consumers should stop using the recalled vials and contact their prescriber or pharmacy for guidance.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste…

  Apollo Care, LLC is recalling its Semaglutide 20mg (5mg/mL) with Glycine 20mg (5mg/mL) 4 mL sterile multi-dose vials, distributed nationwide. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous-type material, posing a risk to patients who inject the product. Consumers should stop using the recalled vials and contact their prescriber or pharmacy for guidance.

  drugs
• openFDA · August 19, 2026Moderate risk

  Prestige Brands Holdings : CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer…

  The recall affects CLEAR EYES Maximum Itchy Eye Relief 0.5 fl oz sterile eye drops, distributed by Medtech Products Inc. for Prestige Consumer Healthcare. The product may be contaminated, so using it poses a risk of eye infection to consumers nationwide. Consumers should stop using the recalled drops and return or discard them according to the recall notice.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO…

  Apollo Care, LLC is recalling Semaglutide 0.9 mg/mL sterile multi-dose vials for subcutaneous injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, posing a risk to patients who inject the product. Consumers should stop using the recalled vials and contact their prescriber or pharmacy for guidance.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO…

  Apollo Care, LLC is recalling Semaglutide 6.75mg (4.5 mg/mL) sterile multi-dose vials. The vials contain particulate matter (nylon/polyamide and silk/proteinaceous material), posing a risk to patients who inject the drug. Consumers should stop using the recalled vials and contact Apollo Care or their healthcare provider for guidance.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste…

  Apollo Care is recalling its Semaglutide 2.5mg (1mg/mL) with Glycine 12.5 mg (5mg/mL) sterile multi-dose vials for subcutaneous injection. The vials contain particulate matter, nylon/polyamide and silk/proteinaceous material, posing a risk to patients who inject the drug. Consumers should stop using the recalled vials and return them to the pharmacy or contact Apollo Care.

  drugs
• openFDA · August 19, 2026Moderate risk

  Heritage Pharmaceuticals Inc : CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816,…

  Heritage Pharmaceuticals Inc. is recalling clindamycin palmitate hydrochloride for oral solution, 75 mg/5 mL, 100 mL, distributed by Avet Pharmaceuticals Inc. The hazard is the presence of particles and white flakes in the reconstituted bottles, posing a risk to patients taking this prescription antibiotic. Consumers should stop using the recalled product and consult their healthcare provider.

  drugs
• openFDA · August 19, 2026High risk

  Liebel-Flarsheim Company LLC : Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution,…

  Liebel-Flarsheim Company LLC is recalling Optiray Imaging Bulk Package-350 (ioversol injection 74%) in 500 mL vials. The vials may contain particulate matter such as polyethylene, plastic, stainless steel, and glass, posing a risk to patients receiving the injection. Consumers should stop using the recalled vials and contact their healthcare provider or pharmacy for instructions.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO…

  Apollo Care, LLC is recalling its Semaglutide 2.25mg (0.9 mg/mL) sterile multi-dose vials sold under the Apollo Care brand. The vials contain particulate matter, including nylon/polyamide and silk/proteinaceous material, posing a risk to patients who inject the drug. Consumers should stop using the recalled vials and contact Apollo Care or their pharmacy for return instructions.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO…

  Apollo Care is recalling Semaglutide 12.5mg (2.5mg/mL), 5 mL sterile multi-dose vials for subcutaneous injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, posing a risk to patients nationwide. Consumers should stop using the recalled vials and contact Apollo Care or their pharmacist for instructions.

  drugs
• openFDA · August 19, 2026High risk

  Victory Medical Center Pharmacy : Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile…

  Victory Medical Center Pharmacy is recalling Glutathione (MDV) 200 mg/mL, 30 mL vials. The sterile injection may contain bacterial endotoxin, posing infection risk to patients who use it. Consumers should stop using the product and return it to the pharmacy or contact their healthcare provider.

  drugs
• openFDA · August 19, 2026Moderate risk

  Apollo Care, LLC : SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste…

  Apollo Care, LLC is recalling semaglutide 7.5 mg (5 mg/mL) with glycine 7.5 mg (5 mg/mL) in 1.5 mL sterile multi-dose vials for subcutaneous injection. The vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material, posing a risk to patients who inject the drug. Consumers should stop using the recalled vials and contact their healthcare provider or pharmacist for instructions.

  drugs
• openFDA · August 19, 2026Moderate risk

  Shoolin Pharma Chem LLP : SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani…

  The recall affects Sildenafil Citrate USP, 100 gm bags, from Shoolin Pharma Chem LLP, distributed nationwide in the USA. The hazard is CGMP deviations found during an FDA inspection, exposing patients who receive compounded prescriptions made with this ingredient. Consumers should stop using the product and contact their pharmacist or prescriber for return and guidance.

  drugs
• openFDA · August 19, 2026High risk

  Buy-Herbal : Kian Pee Wan Capsules, 30-count bottles

  Buy-Herbal brand Kian Pee Wan Capsules, 30-count bottles, are recalled. The capsules contain undeclared dexamethasone and cyproheptadine, posing risks to consumers who bought them from an eBay third-party seller. Consumers should stop using the product and return it to the seller or discard it.

  drugs

Data comes from official CPSC and FDA publications (United States). Summaries are generated automatically from those publications: the cited source prevails.